Get our weekly newsletter that 322K+ startup teams read
All NFX Content 443
All NFX Content · 443
Unlocking The New Industrial Revolution
The Case for Venture Capital in the Age of Superintelligence
Why We Were First Money Into Blitzy
Functional AGI is Already Here
The Last Problem For AI to Solve is Health
AI Zen
The Infinite Game: What Artists Know That Founders Don’t
Software with a Soul: AI’s Underestimated Frontier
What Comes Next Is Bigger Than SaaS Ever Was
Ports, Rails, Roads, and Orbits
“Find a Way to Break Reality”: How Centivax Brought a Universal Flu Vaccine to Clinic
The Stack Above the Cloud
AI Games Are Coming
The Screenless Startup: A New Philosophy For AI Applications
Ask NFX: James Currier on When to Pivot, What to Ignore, and How to Move Faster
In Vitro, In Vivo, In China: How Early-Stage Companies Are Reaching the Clinic Faster Than Ever
Promoting Anastasia Budinskaya to Principal
The 5 Ideas That Defined 2025 – According to Founders
The Founder’s Guide to JPM
1,000 Simultaneous Experiments: The Next Mental State for Founders
Three Reasons Why NFX Invested in On Me: The Product Turning Gift Cards into Networks
The Hidden Structure Behind Today’s Fastest Startups
Why NFX Invested in Cyclana Bio: A Bioplatform Building Physiologically Accurate Human Tissue Models
NFX’s $325M Fund IV and the Turning Point
Unlocking The New Industrial Revolution
The Case for Venture Capital in the Age of Superintelligence
Why We Were First Money Into Blitzy
Functional AGI is Already Here
The Last Problem For AI to Solve is Health
AI Zen
The Infinite Game: What Artists Know That Founders Don’t
Software with a Soul: AI’s Underestimated Frontier
What Comes Next Is Bigger Than SaaS Ever Was
Ports, Rails, Roads, and Orbits
“Find a Way to Break Reality”: How Centivax Brought a Universal Flu Vaccine to Clinic
The Stack Above the Cloud
AI Games Are Coming
The Screenless Startup: A New Philosophy For AI Applications
Ask NFX: James Currier on When to Pivot, What to Ignore, and How to Move Faster
In Vitro, In Vivo, In China: How Early-Stage Companies Are Reaching the Clinic Faster Than Ever
Promoting Anastasia Budinskaya to Principal
The 5 Ideas That Defined 2025 – According to Founders
The Founder’s Guide to JPM
1,000 Simultaneous Experiments: The Next Mental State for Founders
Three Reasons Why NFX Invested in On Me: The Product Turning Gift Cards into Networks
The Hidden Structure Behind Today’s Fastest Startups
Why NFX Invested in Cyclana Bio: A Bioplatform Building Physiologically Accurate Human Tissue Models
NFX’s $325M Fund IV and the Turning Point
Load More Content